BioSpace News Archive

Children’s National Health System announced the opening of a unique chimeric antigen receptor T-cell immunotherapy trial for pediatric patients with relapsed positive acute lymphoblastic leukemia.

Five-month growing trial on high-wire tomatoes conducted by Wageningen and Vortus demonstrates full-spectrum LEDs from Fluence by OSRAM are a viable solution to replace legacy HPS fixtures

Corporate satellite meeting and numerous scientific posters feature new Asuragen products

Nordic Nanovector ASA announces that the company and its collaborators will present data and analyses from its preclinical studies with Betalutin® and with 212Pb-NNV003, a next-generation targeted alpha therapy comprising Nordic Nanovector’s chimeric anti-CD37 antibody coupled with the alpha-particle-generator lead-212, at the Society of Nuclear Medicine & Molecular Imaging 2019 Annual Meeting, to be held in Anaheim, CA, USA on 22-24 June.

GT Healthcare Capital Partners has launched an AI-driven drug development company in Shanghai with $27 million financial backing today.

Oral thin films provide a convenient and accurate delivery system with increased bioavailability of cannabis active ingredients for patients

Leading Behavioral Healthcare Centers Become First National Providers to Add FDA-approved Esketamine Nasal Spray to Treatment Options

Kareo Further Strengthens Board of Directors with Appointment of Scott Maxwell and David Cozzens

On Tuesday, June 18, 2019, Cardiovascular Systems’ Chairman, President and Chief Executive Officer, Scott Ward, will present at the Raymond James Life Sciences & MedTech Conference at 9:45 a.m. Eastern Time.

TrialResults.com helps lead the way in assisting clinical trial sponsors to #BeTransparent